SKI Market

Indian Indices

Sensex

81,666.46 943.52
( 1.17%)

Global Indices

Nasdaq

48,928.31 -164.26
(-0.33%)

Dow Jones

6,963.16 -26.85
(-0.38%)

Hang Seng

52,813.31 -509.54
(-0.96%)

Nikkei 225

10,322.91 99.37
(0.97%)

Forex

USD-INR

91.66 -0.27
(-0.29%)

EUR-INR

108.61 -1.36
(-1.24%)

GBP-INR

125.41 -1.53
(-1.21%)

JPY-INR

0.59 -0.01
(-1.35%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Lyka Labs Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500259

INE933A01014

37.0210703

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

LYKALABS

256.93

EPS(TTM)

Face Value()

Div & Yield %

Back

Board of Tata Consultancy Services recommends Third Interim Dividend

Jan 12,2026

Tata Consultancy Services announced that the Board of Directors of the Company at its meeting held on 12 January 2026, has recommended a Third Interim Dividend of Rs.11 per share (i.e.1100%), subject to the approval of the shareholders.

81,666.46 943.52 ( 1.17%)

48,928.31 -164.26 (-0.33%)

6,963.16 -26.85 (-0.38%)

52,813.31 -509.54 (-0.96%)

10,322.91 99.37 (0.97%)

91.66 -0.27 (-0.29%)

108.61 -1.36 (-1.24%)

125.41 -1.53 (-1.21%)

0.59 -0.01 (-1.35%)